Log in

Relevant bibliographies by topics / ABO-incompatible / Journal articles

To see the other types of publications on this topic, follow the link: ABO-incompatible.

Journal articles on the topic 'ABO-incompatible'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'ABO-incompatible.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Altynova, Venera, Nazym Nigmatullina, Saltanat Rakhimzhanova, Nagima Mustapaeva, and Samat Isakov. "ABO incompatible transplantation." Journal of Clinical Medicine of Kazakhstan 2, no. 44 (2017): 10–14. http://dx.doi.org/10.23950/1812-2892-jcmk-00360.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Curran, David. "ABO incompatible transplantation." Journal of Renal Nursing 3, no. 4 (2011): 161. http://dx.doi.org/10.12968/jorn.2011.3.4.161.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Dunbar, Nancy M., Deborah L. Ornstein, and Larry J. Dumont. "ABO incompatible platelets." Current Opinion in Hematology 19, no. 6 (2012): 475–79. http://dx.doi.org/10.1097/moh.0b013e328358b135.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Dunn, Lauren K., Emily Venner, Matthew Nguyen, et al. "ABO-identical versus incompatible platelet transfusion in patients with intracranial hemorrhage." PLOS ONE 19, no. 11 (2024): e0312602. http://dx.doi.org/10.1371/journal.pone.0312602.

Full text

Abstract:

Background Patients with spontaneous and traumatic intracranial hemorrhage (ICH) are frequently transfused platelets to treat thrombocytopenia, platelet function defects, and reverse antiplatelet drugs. ABO-identical platelet transfusion has been suggested to lead to higher post-transfusion platelet increments compared to major-ABO incompatible transfusion. We hypothesized that patients who received ABO-identical transfusion would have higher post-transfusion platelet increments and superior neurologic outcomes. Methods Adults with traumatic or non-traumatic ICH from January 1st 2018 to Decemb

APA, Harvard, Vancouver, ISO, and other styles

5

Hamal, Saurav S., Rabin Nepali, Sujeet Poudyal, and Dibya S. Shah. "Outcome of ABO-Incompatible Living Donor Kidney Transplantation: A Single Center Observational Study from Nepal." Journal of Institute of Medicine Nepal 45, no. 1 (2023): 45–49. http://dx.doi.org/10.59779/jiomnepal.1251.

Full text

Abstract:

Introduction: Kidney transplantation is the most effective treatment for end-stage renal disease (ESRD) patients. However, the increasing number of ESRD patients and the limited availability of living and cadaveric donors has led to a growing waiting list for kidney transplantation. ABO-incompatible transplantation has emerged as an alternative for these patients in Nepal. Methods: This was an observational study of all the patients who underwent kidney transplantation from March 2017-Feb 2019. Data on demography of recipients and donor, blood group, human leukocyte antigen mismatch, induction

APA, Harvard, Vancouver, ISO, and other styles

6

Toma, Hiroshi. "ABO-INCOMPATIBLE RENAL TRANSPLANTATION." Urologic Clinics of North America 21, no. 2 (1994): 299–310. http://dx.doi.org/10.1016/s0094-0143(21)00947-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Takahashi, Kota. "ABO-incompatible organ transplantation." Current Opinion in Organ Transplantation 12, no. 4 (2007): 409–14. http://dx.doi.org/10.1097/mot.0b013e32823ecfe0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Parra-Ávila, Idalia. "Trasplante renal ABO incompatible." Revista Mexicana de Trasplantes 9, S1 (2020): 120–24. http://dx.doi.org/10.35366/93501.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Hageman, M., N. Michaud, I. Chinnappan, T. Klein, and B. Mettler. "ABO-incompatible heart transplants." Perfusion 30, no. 3 (2014): 209–12. http://dx.doi.org/10.1177/0267659114538895.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Subramanian, V., S. Ramachandran, C. Klein, et al. "ABO-incompatible organ transplantation." International Journal of Immunogenetics 39, no. 4 (2012): 282–90. http://dx.doi.org/10.1111/j.1744-313x.2012.01101.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Stegall, Mark D., Patrick G. Dean, and James M. Gloor. "ABO-Incompatible Kidney Transplantation." Transplantation 78, no. 5 (2004): 635–40. http://dx.doi.org/10.1097/01.tp.0000136263.46262.0d.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Gloor, James M., and Mark D. Stegall. "ABO incompatible kidney transplantation." Current Opinion in Nephrology and Hypertension 16, no. 6 (2007): 529–34. http://dx.doi.org/10.1097/mnh.0b013e3282f02218.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Takahashi, Kota, and Kazuhide Saito. "ABO-incompatible kidney transplantation." Transplantation Reviews 27, no. 1 (2013): 1–8. http://dx.doi.org/10.1016/j.trre.2012.07.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Currie, Ian S., and Lorna K. Henderson. "ABO-incompatible renal transplantation." Lancet 393, no. 10185 (2019): 2014–16. http://dx.doi.org/10.1016/s0140-6736(19)30296-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Bacon, John M., and Ian F. Young. "ABO incompatible blood transfusion." Pathology 21, no. 3 (1989): 181–84. http://dx.doi.org/10.3109/00313028909061055.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Urschel, Simon, and Lori J. West. "ABO-incompatible heart transplantation." Current Opinion in Pediatrics 28, no. 5 (2016): 613–19. http://dx.doi.org/10.1097/mop.0000000000000398.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Yaich, Soumaya. "ABO-Incompatible kidney transplantation." Saudi Journal of Kidney Diseases and Transplantation 24, no. 3 (2013): 463. http://dx.doi.org/10.4103/1319-2442.111009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Lee, Shina, and Duk-Hee Kang. "ABO-Incompatible Kidney Transplantation." Ewha Medical Journal 38, no. 1 (2015): 7. http://dx.doi.org/10.12771/emj.2015.38.1.7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Tanabe, Kazunari. "ABO-incompatible kidney transplantation." Current Opinion in Organ Transplantation 10, no. 3 (2005): 198–202. http://dx.doi.org/10.1097/01.mot.0000174045.52697.41.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Abboud, Imad, Marie-Noëlle Peraldi, and Denis Glotz. "Transplantation Rénale Abo Incompatible." Lebanese Medical Journal 63, no. 3 (2015): 159–63. http://dx.doi.org/10.12816/0015840.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Pierson, R. N., J. Moore, R. M. Merion, and A. M. I. Azimzadeh. "ABO-incompatible lung transplantation." International Congress Series 1292 (July 2006): 63–69. http://dx.doi.org/10.1016/j.ics.2006.03.052.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Rostaing, L., A. Allal, F. Sallusto, et al. "Greffe rénale ABO-incompatible." EMC - Néphrologie 27, no. 2 (2015): 1–10. https://doi.org/10.1016/s1762-0945(14)50638-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

de Weerd, Annelies E., and Michiel G. H. Betjes. "ABO-Incompatible Kidney Transplant Outcomes." Clinical Journal of the American Society of Nephrology 13, no. 8 (2018): 1234–43. http://dx.doi.org/10.2215/cjn.00540118.

Full text

Abstract:

Background and objectivesABO blood group–incompatible kidney transplantation is considered a safe procedure, with noninferior outcomes in large cohort studies. Its contribution to living kidney transplantation programs is substantial and growing. Outcomes compared with center-matched ABO blood group–compatible control patients have not been ascertained.Design, setting, participants, & measurementsComprehensive searches were conducted in Embase, Medline, Cochrane, Web-of-Science, and Google Scholar. Meta-analyses Of Observational Studies in Epidemiology study guidelines for observational st

APA, Harvard, Vancouver, ISO, and other styles

24

Yan, Jiawei, Guangyu Sun, Wen Yao, et al. "Impact of ABO Incompatibility on Engraftment , Transfusion Requirement and Survival after Unrelated Cord Blood Transplantation：a Single Institute Experience in China." Blood 124, no. 21 (2014): 2586. http://dx.doi.org/10.1182/blood.v124.21.2586.2586.

Full text

Abstract:

Abstract Few reports have focused on the impact of ABO incompatibility on the clinical outcomes, after unrelated cord blood transplantation (UCBT). Therefore, we retrospectively analyzed the impact of ABO mismatching on the clinical outcomes of 177 patients with hematologic malignancies, which underwent single UCBT in Anhui Provincial Hospital from May 2008 to April 2014. The study patients included 86 ABO-identical, 52 minor, 32 major, and 11 bidirectional ABO-incompatible recipients. All of them received a homogeneous intensified myeloablative pre-transplantation conditioning regimen of tota

APA, Harvard, Vancouver, ISO, and other styles

25

Uchida, K., Y. Tominaga, T. Haba, et al. "Abo-incompatible renal transplantation—dissociation of abo antibodies." Transplantation Proceedings 30, no. 5 (1998): 2302–3. http://dx.doi.org/10.1016/s0041-1345(98)00631-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Magid-Bernstein, Jessica, Charles B. Beaman, Fernanda Carvalho-Poyraz, et al. "Impacts of ABO-incompatible platelet transfusions on platelet recovery and outcomes after intracerebral hemorrhage." Blood 137, no. 19 (2021): 2699–703. http://dx.doi.org/10.1182/blood.2020008381.

Full text

Abstract:

Abstract Acute platelet transfusion after intracerebral hemorrhage (ICH) given in efforts to reverse antiplatelet medication effects and prevent ongoing bleeding does not appear to improve outcome and may be associated with harm. Although the underlying mechanisms are unclear, the influence of ABO-incompatible platelet transfusions on ICH outcomes has not been investigated. We hypothesized that patients with ICH who receive ABO-incompatible platelet transfusions would have worse platelet recovery (using absolute count increment [ACI]) and neurological outcomes (mortality and poor modified Rank

APA, Harvard, Vancouver, ISO, and other styles

27

Fung, Mark K., Katharine A. Downes, and Ira A. Shulman. "Transfusion of Platelets Containing ABO-Incompatible Plasma: A Survey of 3156 North American Laboratories." Archives of Pathology & Laboratory Medicine 131, no. 6 (2007): 909–16. http://dx.doi.org/10.5858/2007-131-909-topcap.

Full text

Abstract:

Abstract Context.—Hemolytic transfusion reactions due to platelet transfusions containing ABO-incompatible plasma (ie, group O platelets into a non–group O patient) have been reported in the literature. However, limited data describe the extent to which transfusion services manage such platelet transfusions or the methods used to limit the risk of such reactions. Objective.—To determine transfusion services' current practices regarding the use of platelets containing ABO-incompatible plasma. Design.—In a College of American Pathologists' Transfusion Medicine Proficiency Testing Survey, supplem

APA, Harvard, Vancouver, ISO, and other styles

28

Goralczyk, Armin D., Aiman Obed, Andreas Schnitzbauer, et al. "Adult Living Donor Liver Transplantation with ABO-Incompatible Grafts: A German Single Center Experience." Journal of Transplantation 2009 (2009): 1–8. http://dx.doi.org/10.1155/2009/759581.

Full text

Abstract:

Adult living donor liver transplantations (ALDLTs) across the ABO blood group barrier have been reported in Asia, North Americas, and Europe, but not yet in Germany. Several strategies have been established to overcome the detrimental effects that are attached with such a disparity between donor and host, but no gold standard has yet emerged. Here, we present the first experiences with three ABO-incompatible adult living donor liver transplantations in Germany applying different immunosuppressive strategies. Four patient-donor couples were considered for ABO-incompatible ALDLT. In these patien

APA, Harvard, Vancouver, ISO, and other styles

29

Sanford, Kimberly, Natalie Case, Benjamin Blake, Tabitha Michaud, Richard A. McPherson, and Susan D. Roseff. "Changes in Mean Corpuscular Volume and RBC Distribution Width Predict Erythrocyte Engraftment Following ABO-Incompatible Hematopoietic Stem Cell Transplantation." American Journal of Clinical Pathology 153, no. 6 (2020): 781–89. http://dx.doi.org/10.1093/ajcp/aqaa006.

Full text

Abstract:

Abstract Objectives The purpose of this study was to identify laboratory parameters representing erythrocyte engraftment to be used as an indicator to change the recipient to donor ABO group and Rh type following an ABO-incompatible hematopoietic stem cell transplant (HSCT). Studies have shown that ABO incompatibility does not have an effect on outcome of HSCT; however, the serologic consequences of these ABO-incompatible transplants can make it difficult to decide when to begin support with donor ABO/Rh-type blood products. Methods This study explored the use of RBC distribution width (RDW),

APA, Harvard, Vancouver, ISO, and other styles

30

Gajewski, JL, LD Petz, L. Calhoun, et al. "Hemolysis of transfused group O red blood cells in minor ABO- incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate." Blood 79, no. 11 (1992): 3076–85. http://dx.doi.org/10.1182/blood.v79.11.3076.3076.

Full text

Abstract:

Abstract Hemolysis most commonly occurs following bone marrow transplant when there is “minor” ABO blood group incompatibility between donor and recipient. The hemolysis has been attributed to destruction of the patient's incompatible erythrocytes by donor-derived anti-A and/or anti- B antibody produced from “passenger” immunocompetent donor lymphocytes. Extraordinary transfusion requirements of group O erythrocytes in a series of patients receiving unrelated minor ABO-incompatible marrow grafts led us to investigate whether this mechanism could account for the extent of hemolysis observed. In

APA, Harvard, Vancouver, ISO, and other styles

31

Gajewski, JL, LD Petz, L. Calhoun, et al. "Hemolysis of transfused group O red blood cells in minor ABO- incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate." Blood 79, no. 11 (1992): 3076–85. http://dx.doi.org/10.1182/blood.v79.11.3076.bloodjournal79113076.

Full text

Abstract:

Hemolysis most commonly occurs following bone marrow transplant when there is “minor” ABO blood group incompatibility between donor and recipient. The hemolysis has been attributed to destruction of the patient's incompatible erythrocytes by donor-derived anti-A and/or anti- B antibody produced from “passenger” immunocompetent donor lymphocytes. Extraordinary transfusion requirements of group O erythrocytes in a series of patients receiving unrelated minor ABO-incompatible marrow grafts led us to investigate whether this mechanism could account for the extent of hemolysis observed. In seven co

APA, Harvard, Vancouver, ISO, and other styles

32

Strüber, M., G. Warnecke, C. Hafer, et al. "Intentional ABO-Incompatible Lung Transplantation." American Journal of Transplantation 8, no. 11 (2008): 2476–78. http://dx.doi.org/10.1111/j.1600-6143.2008.02405.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Mohacsi, P., R. Rieben, and U. E. Nydegger. "Immunosuppression in ABO-incompatible transplantation." Transplantation Proceedings 33, no. 3 (2001): 2223–24. http://dx.doi.org/10.1016/s0041-1345(01)01947-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Warner, Paul R., and Theresa A. Nester. "ABO-Incompatible Solid-Organ Transplantation." Pathology Patterns Reviews 125, suppl_1 (2006): S87—S94. http://dx.doi.org/10.1309/8w4x9h6f8ftlcgyx.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Yoon, Y. I., K. H. Kim, G. W. Song, S. G. Lee, T. Y. Ha, and G. C. Park. "ABO incompatible LDLT for HCC." HPB 18 (April 2016): e19. http://dx.doi.org/10.1016/j.hpb.2016.02.052.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Zimin, Sun, Ji Mengmeng, Yao Wen, et al. "Impact Of ABO Incompatibility On Overall Survival After Unrelated Cord Blood Transplantation a Single Institute Experience In China." Blood 122, no. 21 (2013): 5535. http://dx.doi.org/10.1182/blood.v122.21.5535.5535.

Full text

Abstract:

Abstract Umbilical cord blood transplantation (UCBT) has now become a more common treatment for patients with hematologic malignancies who lack matched related or unrelated donors. However, few reports have addressed the impact of ABO incompatibility on the clinical outcomes, such as engraftment, transfusion requirements and survival after UCBT. Therefore, we retrospectively analyzed the impact of ABO mismatching on the clinical outcomes of 121 patients, including 51 ABO-identical, 23 minor, 39 major, and 8 bidirectional ABO-incompatible recipients after UCBT. With a median follow-up of 11 mon

APA, Harvard, Vancouver, ISO, and other styles

37

Kiyoki, Yusuke, Yumiko Maruyama, Yuzuki Maruyama, et al. "Dynamics of Red Blood Cell Hematopoiesis Following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation." Blood 144, Supplement 1 (2024): 7102. https://doi.org/10.1182/blood-2024-201915.

Full text

Abstract:

[Background] ABO-incompatibility is not thought to be a contraindication for allogeneic hematopoietic stem cell transplantation (allo-HSCT), although the clinical impacts are occasionally debated. Post-transplant pure red blood cell aplasia (p-PRCA) is a disorder of erythropoiesis during the post-transplant immune tolerance process and is a rare complication after ABO-incompatible allo-HSCT. Donor-derived erythropoiesis is clinically predicted by the recovery of reticulocyte number and transfusion independence. However, the dynamics of donor erythropoiesis are complex and are not fully investi

APA, Harvard, Vancouver, ISO, and other styles

38

Shin, Milljae, and Sung-Joo Kim. "ABO Incompatible Kidney Transplantation—Current Status and Uncertainties." Journal of Transplantation 2011 (2011): 1–11. http://dx.doi.org/10.1155/2011/970421.

Full text

Abstract:

In the past, ABO blood group incompatibility was considered an absolute contraindication for kidney transplantation. Progress in defined desensitization practice and immunologic understanding has allowed increasingly successful ABO incompatible transplantation during recent years. This paper focused on the history, disserted outcomes, desensitization modalities and protocols, posttransplant immunologic surveillance, and antibody-mediated rejection in transplantation with an ABO incompatible kidney allograft. The mechanism underlying accommodation and antibody-mediated injury was also described

APA, Harvard, Vancouver, ISO, and other styles

39

Issitt, Richard, Richard Crook, Michael Shaw, and Alex Robertson. "The Great Ormond Street Hospital immunoadsorption method for ABO-incompatible heart transplantation: a practical technique." Perfusion 36, no. 1 (2020): 34–37. http://dx.doi.org/10.1177/0267659120926895.

Full text

Abstract:

Traditionally, ABO-incompatible heart transplantation was accomplished using a plasma exchange technique to remove recipient plasma containing donor-incompatible anti-A/B isohaemagglutinins. However, this technique exposed patients to large volumes of allogeneic blood and blood products (up to three times the patient’s circulating volume). In 2018, we published the first reported case of an ABO-incompatible heart transplant using an intraoperative immunoadsorption technique which minimises the exposure to blood products by specifically targeting anti-A/B isohaemagglutinins. We have subsequentl

APA, Harvard, Vancouver, ISO, and other styles

40

Sumathi, Kotapuri, Mounica Adari, and Raj Chitgupikar Sudharshan. "The Study of Outcomes in Neonates Born to ABO and Rhesus (D) Incompatible Mothers." International Journal of Pharmaceutical and Clinical Research 16, no. 7 (2024): 311–19. https://doi.org/10.5281/zenodo.12772141.

Full text

Abstract:

<strong>Background: </strong>In this study, we wanted to study the outcomes and follow up of ABO and Rh(D) incompatible neonates, to Study the incidence of ABO and Rh(D) incompatible setting, to follow up the neonates with ABO and Rh(D) Incompatible setting, to study the clinical outcomes among them and to initiate a prompt treatment, to propose a discharge plan for neonates with ABO and Rh(D) incompatible setting. <strong>Methods: </strong>This was a Hospital Based Prospective Observational Study conducted among 166 neonates with ABO incompatibility and 28 neonates with Rhesus

APA, Harvard, Vancouver, ISO, and other styles

41

Carvalho Poyraz, Fernanda, Mohamed Ridha, Marialaura Simonetto, et al. "ABO-Incompatible Platelet Transfusion Is Associated with Ischemic Lesions on Brain MRI in Patients with Intracerebral Hemorrhage." Blood 142, Supplement 1 (2023): 1288. http://dx.doi.org/10.1182/blood-2023-186171.

Full text

Abstract:

Background: We have identified that major ABO-incompatible platelet transfusions are associated with poor intracerebral hemorrhage (ICH) outcomes. The underlying drivers for the relationship of these incompatible platelet units on outcome are unknown, yet do not appear to be related to impaired hemostasis. Conversely, ICH patients are known to encounter remote, “silent” ischemic lesions, thought to be from microthrombosis, during their hospitalization. Though these ischemic lesions are well known to associate with poor ICH outcomes, risk factors for its formation are unknown. We explored wheth

APA, Harvard, Vancouver, ISO, and other styles

42

Rao, Nitesh N., Chris Wilkinson, Mark Morton, et al. "Successful pregnancy in a recipient of an ABO-incompatible renal allograft." Obstetric Medicine 12, no. 1 (2018): 42–44. http://dx.doi.org/10.1177/1753495x17745390.

Full text

Abstract:

Kidney transplantation restores fertility in patients with end-stage renal disease, with many successful pregnancies after kidney transplantation being reported. However, there are little data regarding pregnancy in women transplanted under modern-era desensitisation protocols that utilise rituximab, plasma exchange and intravenous immunoglobulin, including ABO-incompatible transplants. Pregnancies in ABO-incompatible recipients can pose new challenges from an immunological perspective. Here, we report a case of successful pregnancy using in vitro fertilisation, in a renal transplant recipient

APA, Harvard, Vancouver, ISO, and other styles

43

Kimura, Fumihiko, Ken Sato, Shinichi Kobayashi, et al. "Impacts of ABO-Blood Type Incompatibility on Outcome of Unrelated Bone Marrow Transplantation through the Japan Marrow Donor Program." Blood 108, no. 11 (2006): 173. http://dx.doi.org/10.1182/blood.v108.11.173.173.

Full text

Abstract:

Abstract ABO incompatibility between donor and recipient is not a barrier for successful allogeneic hematopoietic stem cell transplantation, but conflicting data still exist concerning its influence on transplant outcome, graft-versus-host disease (GVHD), relapse, and survival. We retrospectively analyzed the data of patients who underwent UR-BMT through the Japan Marrow Donor Program between January 1993 and September 2005, with complete data on ABO-blood group compatibility, age, and gender in donors and recipients. A total of 4,970 patients were transplanted with marrow from ABO-matched (M;

APA, Harvard, Vancouver, ISO, and other styles

44

Tsuji, Masanori, Atsushi Wake, Naoyuki Uchida, et al. "Impact of ABO Imcompatibility On Acute GvHD and Thrombotic Microangiopathy After Reduced-Intensity Cord Blood Transplantation." Blood 114, no. 22 (2009): 2298. http://dx.doi.org/10.1182/blood.v114.22.2298.2298.

Full text

Abstract:

Abstract Abstract 2298 Poster Board II-275 Introduction: Althouth ABO blood type is one of two antigen system for transplantation, the effect of ABO incompatibility on transplantation outcome still remains controversy. Furthermore, there is little data about ABO incompatibility on the outcome of unrelated cord blood transplantation following reduced-intensity conditioning (RI-CBT). Design and Methods: We retrospectively analyzed data of 155 patients who underwent RI-CBT performed at Toranomon Hospital from January 2005 to December 2008. The patients include 45 ABO-identical, 47 minor, 43 major

APA, Harvard, Vancouver, ISO, and other styles

45

Rodriguez, Rose J., Linda J. Addonizio, Jacqueline M. Lamour, et al. "Pediatric Heart Transplantation across ABO Blood Type Barriers: A Case Study." Progress in Transplantation 15, no. 2 (2005): 161–65. http://dx.doi.org/10.1177/152692480501500209.

Full text

Abstract:

Heart transplantation with ABO blood type–incompatible donors has historically been contraindicated because of the high risk of an immediate hyperacute humoral graft rejection. The immature neonatal immune system presents an immunologic window that allows for breaching the ABO barrier before the natural development of anti-ABO antibodies. Information from a small series of neonates has demonstrated similar survival rates and posttransplant outcomes compared to ABO-compatible transplantations. In the posttransplant period, particular attention is placed on the surveillance of graft-specific ant

APA, Harvard, Vancouver, ISO, and other styles

46

Gmur, JP, J. Burger, A. Schaffner, et al. "Pure red cell aplasia of long duration complicating major ABO- incompatible bone marrow transplantation [see comments]." Blood 75, no. 1 (1990): 290–95. http://dx.doi.org/10.1182/blood.v75.1.290.bloodjournal751290.

Full text

Abstract:

In 3 of 15 consecutive patients receiving a human leukocyte antigen (HLA)-identical but major ABO incompatible bone marrow transplant (BMT), pure red cell aplasia (PRA) lasting 5 to 8 months was observed. Titers of the incompatible anti-A agglutinin before infusion of the red blood cell (RBC)-depleted BMT was very high in one, and in the usual range in two patients. Decrease of agglutinin titers during the first 4 weeks after BMT were comparable between PRA patients and those of ABO- incompatible BMT recipients with timely RBC recovery. However, in PRA patients, agglutinin titers rose again an

APA, Harvard, Vancouver, ISO, and other styles

47

Kaplan, M., C. Hammerman, and S. U. Sarici. "Familial Hyperbilirubinemia in ABO-Incompatible Neonates." PEDIATRICS 112, no. 6 (2003): 1453–54. http://dx.doi.org/10.1542/peds.112.6.1453.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Kim, Jong Man. "ABO-Incompatible Living Donor Liver Transplantation." Journal of the Korean Society for Transplantation 28, no. 1 (2014): 1. http://dx.doi.org/10.4285/jkstn.2014.28.1.1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

West, Lori J. "ABO-incompatible hearts for infant transplantation." Current Opinion in Organ Transplantation 16, no. 5 (2011): 548–54. http://dx.doi.org/10.1097/mot.0b013e32834a97a5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

West, Lori J., Stacey M. Pollock-Barziv, Anne I. Dipchand, et al. "ABO-Incompatible Heart Transplantation in Infants." New England Journal of Medicine 344, no. 11 (2001): 793–800. http://dx.doi.org/10.1056/nejm200103153441102.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!